We therefore predicted that the enforced expression of huMETCAM/MUC18 may affect tumorigenesis by altering the expression of its downstream effectors, such as the indexes of apoptosis/anti-apoptosis, proliferation, survival, aerobic glycolysis, and angiogenesis, in the tumor cells. Here, MCAM is linked to neoplasm.